Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Keratosis, Actinic 27 Carcinoma, Basal Cell 12 Uterine Cervical Dysplasia 11 Melanoma 7 Glioma 4 Glioblastoma 4 Condylomata Acuminata 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Papillomavirus Infections 3 Keratosis 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Precancerous Conditions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Hutchinson's Melanotic Freckle 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Oxaliplatin 252 Capecitabine 175 Fluorouracil 162 Cisplatin 139 Docetaxel 120 S 1 (combination) 115 Leucovorin 108 Paclitaxel 107 Irinotecan 97 pembrolizumab 80 Trastuzumab 57 apatinib 54 Nivolumab 47 Drug Therapy 46 Surgical Procedures, Operative 38 sintilimab 36 Radiotherapy 36 Ramucirumab 34 Bevacizumab 34 tislelizumab 29 Hyperthermic Intraperitoneal Chemotherapy 29 Epirubicin 29 titanium silicide 26 Carboplatin 26 XELOX 24 Gastrectomy 24 Cyclophosphamide 24 Folfox protocol 20 Tegafur 19 Cetuximab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡